Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.

Autor: Alias A; Department of Rheumatology, University of South Florida, Tampa, Florida 33612, USA., Rodriguez EJ, Bateman HE, Sterrett AG, Valeriano-Marcet J
Jazyk: angličtina
Zdroj: Bulletin of the NYU hospital for joint diseases [Bull NYU Hosp Jt Dis] 2012; Vol. 70 (2), pp. 109-14.
Abstrakt: Objective: Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.
Methods: A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.
Results: Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.
Conclusion: Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.
Databáze: MEDLINE